Who to call at Cagent Vascular, and when
Fundz watches for the moments Cagent Vascular starts buying, and tells you who to reach.
- An alert the day Cagent Vascular raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cagent Vascular, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cagent Vascular. With Fundz connected, it knows.
Watch Fundz in
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
Cagent Vascular and 3comma Medical Announce Strategic Partnership to Expand International Distribution of Serranator Product Family
Apr 03, 2025
Contract Type
partnership
WayneHealthcareHealth CareDescription
Cagent Vascular, Inc. announced a strategic partnership with 3comma Medical GmbH to expand the international distribution of the Serranator Product Family in EU and MENA regions for the treatment of peripheral artery disease (PAD) and chronic limb threatening ischemia (CLTI).
Related People
Agreement Insights
What this usually meansStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Cagent Vascular signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.